Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1076368

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1076368

Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report By Product (Accu-Chek Inform II, Freestyle Lite), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2022 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Point-of-Care Glucose Testing Market Growth & Trends:

The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period, according to a new report by Grand View Research, Inc. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years. As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings. The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.

Various companies are investing in the development of needle-less devices to offer painless management of diabetes. For instance, GlucoTrack, a product manufactured by Integrity Applications (Israel), performs quantification using electromagnetic, ultrasonic, and thermal waves in combination. Eversense, painless glucose monitoring subcutaneous implant by Senseonics, quantifies glucose levels in interstitial fluid when placed beneath the skin. This is followed by data transmission to show the results in real-time. The latest no-code monitoring systems help in minimizing the errors that occur due to incorrect entry of strip codes. Whereas, others are incorporating noble metals, such as silver, gold, and platinum, which effectively reduce the electrical noise further improving accuracy.

Point-of-Care Glucose Testing Market Report Highlights:

  • Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period
  • Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030
  • North America is the leading regional market due to the higher penetration of novel diagnostic techniques
  • Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics
  • Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region
Show more
Product Code: GVR-4-68038-134-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Introduction of CLIA waived tests
      • 3.4.1.2. Growing prevalence of diabetes
      • 3.4.1.3. Rising demand for short turnaround time glucose POC testing
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Potential interference and calibration issues in glucose meters
      • 3.4.2.2. Presence of ambiguous regulatory as well as reimbursement framework
  • 3.5. Point-of-Care(POC) Glucose Testing Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Accu-Check Aviva Meter
    • 4.1.2. Onetouch Verio Flex
    • 4.1.3. i-STAT
    • 4.1.4. Freestyle Lite
    • 4.1.5. Bayer CONTOUR Blood Glucose Monitoring System
    • 4.1.6. True Metrix
    • 4.1.7. Accu-Check Inform II
    • 4.1.8. StatStrip
    • 4.1.9. Others
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Point-of-Care (POC) Glucose Testing Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Accu-Check Aviva Meter
      • 4.5.1.1. Accu-Check Aviva Meter market estimates and forecast, 2018 - 2030
    • 4.5.2. Onetouch Verio Flex
      • 4.5.2.1. Onetouch Verio Flex market estimates and forecast, 2018 - 2030
    • 4.5.3. i-STAT
      • 4.5.3.1. I-STAT market estimates and forecast, 2018 - 2030
    • 4.5.4. Freestyle Lite
      • 4.5.4.1. Freestyle Lite market estimates and forecast, 2018 - 2030
    • 4.5.5. Bayer Contour Blood Glucose Monitoring System
      • 4.5.5.1. Bayer Contour Blood Glucose Monitoring System market estimates and forecast, 2018 - 2030
    • 4.5.6. True Metrix
      • 4.5.6.1. TRUE METRIX market estimates and forecast, 2018 - 2030
    • 4.5.7. Accu-Check Inform II
      • 4.5.7.1. Accu-Check Inform II market estimates and forecast, 2018 - 2030
    • 4.5.8. StatStrip
      • 4.5.8.1. StatStrip market estimates and forecast, 2018 - 2030
    • 4.5.9. Others
      • 4.5.9.1. Others market estimates and forecast, 2018 - 2030

Chapter 5. Point-of-Care (POC) Glucose Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2018 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2021
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa
  • 5.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2028:
  • 5.7. North America
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.7.2. U.S.
      • 5.7.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.7.3. Canada
      • 5.7.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
  • 5.8. Europe
    • 5.8.1. U.K.
      • 5.8.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.8.2. Germany
      • 5.8.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.8.3. France
      • 5.8.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.8.4. Italy
      • 5.8.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.8.5. Spain
      • 5.8.5.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.8.6. Russia
      • 5.8.6.1. Market estimates and forecast, 2018 - 2030 (USD million)
  • 5.9. Asia Pacific
    • 5.9.1. Japan
      • 5.9.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.9.2. China
      • 5.9.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.9.3. India
      • 5.9.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.9.4. Australia
      • 5.9.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.9.5. Thailand
      • 5.9.5.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.9.6. South Korea
      • 5.9.6.1. Market estimates and forecast, 2018 - 2030 (USD million)
  • 5.10. Latin America
    • 5.10.1. Brazil
      • 5.10.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.10.2. Mexico
      • 5.10.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.10.3. Argentina
      • 5.10.3.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.10.4. Colombia
      • 5.10.4.1. Market estimates and forecast, 2018 - 2030 (USD million)
  • 5.11. MEA
    • 5.11.1. Saudi Arabia
      • 5.11.1.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.11.2. South Africa
      • 5.11.2.1. Market estimates and forecast, 2018 - 2030 (USD million)
    • 5.11.3. UAE
      • 5.11.3.1. Market estimates and forecast, 2018 - 2030 (USD million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2021
    • 6.3.4. F. Hoffmann-La Roche Ltd.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Abbott
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Nipro
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. PlatInium Equity Advisors, LLC (Lifescan, Inc.)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Nova Biomedical
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. ACON Laboratories
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Trividia Health, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Prodigy Diabetes Care, LLC
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Bayer AG/Ascensia Diabetes Care Holdings AG
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. EKF Diagnostics
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
Show more
Product Code: GVR-4-68038-134-4

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.K. Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 France Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Russia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 14 APAC Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 15 APAC Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Japan Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 China Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 18 India Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 19 Australia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Thailand Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 21 South Korea Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Latin America Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 Latin America Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
  • Table 24 Brazil Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 25 Mexico Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Argentina Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 27 Colombia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 28 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa Point-of-Care (POC) Glucose Testing market, by region, 2018 - 2030 (USD Million)
  • Table 30 South Africa Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 31 Saudi Arabia Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 UAE Point-of-Care (POC) Glucose Testing market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Primary interviews in North America

Fig. 5 Primary interviews in Europe

Fig. 6 Primary interviews in APAC

Fig. 7 Primary interviews in Latin America

Fig. 8 Primary interviews in MEA

Fig. 9 Market research approaches

Fig. 10 Value-chain-based sizing & forecasting

Fig. 11 QFD modeling for market share assessment

Fig. 12 Market formulation & validation

Fig. 13 Point-of-Care (POC) Glucose Testing market: market outlook

Fig. 14 Point-of-Care (POC) Glucose Testing market competitive insights

Fig. 15 Parent market outlook

Fig. 16 Related/ancillary market outlook

Fig. 17 Penetration and growth prospect mapping

Fig. 18 Industry value chain analysis

Fig. 19 Point-of-Care (POC) Glucose Testing market driver impact

Fig. 20 Point-of-Care (POC) Glucose Testing market restraint impact

Fig. 21 Point-of-Care (POC) Glucose Testing market strategic initiatives analysis

Fig. 22 Point-of-Care (POC) Glucose Testing market: product movement analysis

Fig. 23 Point-of-Care (POC) Glucose Testing market: product outlook and key takeaways

Fig. 24 Accu Check Aviva meter market estimates and forecast, 2018 - 2030

Fig. 25 Onetouch Verio Flex market estimates and forecast, 2018 - 2030

Fig. 26 i-STAT market estimates and forecast, 2018 - 2030

Fig. 27 Freestyle Lite market estimates and forecast, 2018 - 2030

Fig. 28 Bayer CONTOUR blood glucose monitoring system market estimates and forecast, 2018 - 2030

Fig. 29 True Metrix market estimates and forecast, 2018 - 2030

Fig. 30 Accu-Chek Inform II market estimates and forecast, 2018 - 2030

Fig. 31 StatStrip market estimates and forecast, 2018 - 2030

Fig. 32 Other market estimates and forecast, 2018 - 2030

Fig. 33 Global Point-of-Care (POC) Glucose Testing market: regional movement analysis

Fig. 34 Global Point-of-Care (POC) Glucose Testing market: regional outlook and key takeaways

Fig. 35 Global market shares and leading players

Fig. 36 North America market share and leading players

Fig. 37 Europe market share and leading players

Fig. 38 Asia Pacific market share and leading players

Fig. 39 Latin America market share and leading players

Fig. 40 Middle East & Africa market share and leading players

Fig. 41 North America: SWOT

Fig. 42 Europe SWOT

Fig. 43 Asia Pacific SWOT

Fig. 44 Latin America SWOT

Fig. 45 MEA SWOT

Fig. 46 North America, by country

Fig. 47 North America

Fig. 48 North America market estimates and forecast, 2018 - 2030

Fig. 49 U.S.

Fig. 50 U.S. market estimates and forecast, 2018 - 2030

Fig. 51 Canada

Fig. 52 Canada market estimates and forecast, 2018 - 2030

Fig. 53 Europe

Fig. 54 Europe. market estimates and forecast, 2018 - 2030

Fig. 55 U.K.

Fig. 56 U.K. market estimates and forecast, 2018 - 2030

Fig. 57 Germany

Fig. 58 Germany market estimates and forecast, 2018 - 2030

Fig. 59 France

Fig. 60 France market estimates and forecast, 2018 - 2030

Fig. 61 Italy

Fig. 62 Italy market estimates and forecast, 2018 - 2030

Fig. 63 Spain

Fig. 64 Spain market estimates and forecast, 2018 - 2030

Fig. 65 Russia

Fig. 66 Russia market estimates and forecast, 2018 - 2030

Fig. 67 Asia Pacific

Fig. 68 Asia Pacific market estimates and forecast, 2018 - 2030

Fig. 69 Japan

Fig. 70 Japan market estimates and forecast, 2018 - 2030

Fig. 71 China

Fig. 72 China market estimates and forecast, 2018 - 2030

Fig. 73 India

Fig. 74 India market estimates and forecast, 2018 - 2030

Fig. 75 Australia

Fig. 76 Australia market estimates and forecast, 2018 - 2030

Fig. 77 Thailand

Fig. 78 Thailand market estimates and forecast, 2018 - 2030

Fig. 79 South Korea

Fig. 80 South Korea market estimates and forecast, 2018 - 2030

Fig. 81 Latin America

Fig. 82 Latin America market estimates and forecast, 2018 - 2030

Fig. 83 Brazil

Fig. 84 Brazil market estimates and forecast, 2018 - 2030

Fig. 85 Mexico

Fig. 86 Mexico market estimates and forecast, 2018 - 2030

Fig. 87 Argentina

Fig. 88 Argentina market estimates and forecast, 2018 - 2030

Fig. 89 Colombia

Fig. 90 Colombia market estimates and forecast, 2018 - 2030

Fig. 91 Middle East and Africa

Fig. 92 Middle East and Africa. market estimates and forecast, 2018 - 2030

Fig. 93 South Africa

Fig. 94 South Africa market estimates and forecast, 2018 - 2030

Fig. 95 Saudi Arabia

Fig. 96 Saudi Arabia market estimates and forecast, 2018 - 2030

Fig. 97 UAE

Fig. 98 UAE market estimates and forecast, 2018 - 2030

Fig. 99 Participant categorization- Point-of-Care (POC) Glucose Testing market

Fig. 100 Market share of key market players- Point-of-Care (POC) Glucose Testing market

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!